Question · asked by 1 review
Dual antiplatelet therapy vs one antiplatelet agent: Stroke or transient ischaemic attack
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Dual antiplatelet therapy vs single antiplatelet therapy Stroke or transient ischaemic attack · people with cerebral small vessel disease and no dementia Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but… (2022) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 3020 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia 2022 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.